Globe Newswire

Dubai, UAE, May 09, 2024 (GLOBE NEWSWIRE) -- Crypto investors are regaining their confidence in the market after a long bear market. Investors are flooding back to the market, assembling their watch lists and deploying capital into new innovative projects to get early returns. One project which stands out from the rest is Panda Swap.

What is Panda Swap?

Panda Swap is a genuinely innovative project, poised to give investors the best return in 2024. $PANDA... (continue reading...)

Dubai, UAE, May 09, 2024 (GLOBE NEWSWIRE) -- Crypto investors are regaining their confidence in the market after a long bear market. Investors are flooding back to the market, assembling their watch lists and deploying capital into new innovative projects to get early returns. One project which stands out from the rest is Panda Swap.

What is Panda Swap?

Panda Swap is a genuinely innovative project, poised to give investors the best return in 2024. $PANDA... (continue reading...)

MIAMI, May 09, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti is proud to announce the next stage of their treatment software's development, which will incorporate matrix theory through the use of a Python script and multidimensional array.

The new programming sequences allow the company to maximize dosing efficiency with an easy-to-use system. David Dardashti, the founder and CEO of Ibogaine, stated, “Our program is already incredibly efficient, but adding... (continue reading...)

ORLANDO, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- Lifelong Labs’ Founder and Wellness Advocate Greg Lindberg unravels in his book Lifelong the mysteries of brain health through an exploration of the Neuroscience of Brain-Derived Neurotrophic Factor (BDNF). As part of his commitment to optimal health and wellness, Lindberg explores the intricate functions of BDNF and its impact on human health, mind and body. Watch Video Here.

BDNF, a protein vital for the growth... (continue reading...)

NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Altimmune, Inc. (NASDAQ: ALT) between December 1, 2023 and April 26, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 5, 2024.

SO WHAT: If you... (continue reading...)